PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Tobramycin - Cystic fibrosis

PAD Profile : Tobramycin - Cystic fibrosis

Keywords :
NICE, antibiotic, antibacterial, aminoglycoside
Brand Names Include :
Tobi, Bramitob, Vantobra

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Inhalation
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NHSE
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
01 April 2013
Not Set
FOR NEW PATIENTS ONLY. Prescribing of Tobramycin will be considered RED on the Prescribing Advisory database. Historically amber for CF patients via nebulisation / inhalation (Not Tobi-Podhaler which has historically been RED). Funding now rests with NHS England for this treatment FOR EXISTING PATIENTS: GPs should continue to prescribe these treatments. NHS England are looking to repatriate these patients in the future. The Medicines Management Team will be in contact with prescribers when they have more information

Associated BNF Codes

05. Infections
05.01.04. Aminoglycosides
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More